Hannah Gill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hannah Gill has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Xun Liu
School of Clinical Sciences, University of Bristol, St Michael's Hospital, Bristol, United Kingdom
6 shared publications- Marianne Thoresen
Department of Physiology, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
4 shared publications - Elisa Smit
Rebekka Manuela Jones Dr. med. univ MRCPCH is a ST8 Neonatal Medicine in the Neonatal Intensive Care Unit, University Hospital of Wales, Cardiff, UK. Conflicts of interest: none
3 shared publications Hemmen Sabir
School of Clinical Sciences, University of Bristol, St Michael's Hospital, Bristol, United Kingdom; Departments of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Düsseldorf, Heinrich-Heine University Düsseldorf, Germany
3 shared publicationsJohn Dingley
College of Medicine, Swansea University, United Kingdom
3 shared publications- Andrew James Shrimpton
University of Bristol Bristol UK
2 shared publications
Latest Publications
- Open Access
- 13 November 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 31 (3) , 372-374
The effects of xenon on sevoflurane anesthesia‐induced acidosis and brain cell apoptosis in immature rats
Anesthesia‐induced neurodegeneration (AIN) occurs in newborn large animal modelswhere physiological homeostasis is maintained. However, most immature rodent models of AINreport mortality ratesand hypercarbia alone, mimicking that produced by anesthesia, increases neuro‐apoptosis1.Thepotential influence of physiological derangement is one reason why rodent models of AIN are notidealfor predicting clinical effect.However, they remain necessary for theinitial pre‐clinical investigation of toxicity or treatment.
- 13 November 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 31 (3) , 372-374
Open AccessThe effects of xenon on sevoflurane anesthesia‐induced acidosis and brain cell apoptosis in immature rats
Anesthesia‐induced neurodegeneration (AIN) occurs in newborn large animal modelswhere physiological homeostasis is maintained. However, most immature rodent models of AINreport mortality ratesand hypercarbia alone, mimicking that produced by anesthesia, increases neuro‐apoptosis1.Thepotential influence of physiological derangement is one reason why rodent models of AIN are notidealfor predicting clinical effect.However, they remain necessary for theinitial pre‐clinical investigation of toxicity or treatment.
- Open Access
- 1 August 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 30 (8) , 941-943
The physiological effect of 1MAC sevoflurane with or without 50% Xenon in immature rats
Anesthetic‐induced neurodegenerationin rats occursacross the first three postnatal weeks1 (human equivalent:fetus to pre‐schooler), during which the central nervous system, respiratory control and pharmacodynamics undergo hugechanges. In immature rats, hypercarbia alone(mimicking isoflurane anesthesia‐induced hypercarbia) induced neurodegeneration2 and Xenon reducesanesthetic‐induced neurodegeneration.
- 1 August 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 30 (8) , 941-943
Open AccessThe physiological effect of 1MAC sevoflurane with or without 50% Xenon in immature rats
Anesthetic‐induced neurodegenerationin rats occursacross the first three postnatal weeks1 (human equivalent:fetus to pre‐schooler), during which the central nervous system, respiratory control and pharmacodynamics undergo hugechanges. In immature rats, hypercarbia alone(mimicking isoflurane anesthesia‐induced hypercarbia) induced neurodegeneration2 and Xenon reducesanesthetic‐induced neurodegeneration.
- 1 June 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 30 (6) , 710-712
Perioperative management of oral cleft repair: A retrospective chart review
- 1 June 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 30 (6) , 710-712
Perioperative management of oral cleft repair: A retrospective chart review
- Open Access
- 16 April 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 30 (6) , 716-719
Airway management for dental clearance in a preschool child: A UK survey
- 16 April 2020
- Published by Wiley in Pediatric Anesthesia
- Vol. 30 (6) , 716-719
Open AccessAirway management for dental clearance in a preschool child: A UK survey
- Open Access
- 1 April 2019
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 128 (4) , 681-694
Assessing Long-term Neurodevelopmental Outcome Following General Anesthesia in Early Childhood: Challenges and Opportunities
Neurodegeneration has been reported in young animals after exposure to all commonly used general anesthetic agents. The brain may be particularly vulnerable to anesthetic toxicity during peak synaptogenesis (in gestation and infancy). Human studies of long-term neurodevelopmental outcome following general anesthesia in early childhood report contradictory findings. This review assesses the strengths and deficiencies in human research methodologies to inform future studies. We identified 76 studies, published between 1990 and 2017, of long-term neurodevelopmental outcome following early childhood or in utero general anesthesia exposure: 49 retrospective, 9 ambidirectional, 17 prospective cohort studies, and 1 randomized controlled trial. Forty-nine studies were explicitly concerned with anesthetic-induced neurotoxicity. Full texts were appraised for methodological challenges and possible solutions. Major challenges identified included delineating effects of anesthesia from surgery, defining the timing and duration of exposure, selection of a surgical cohort and intervention, addressing multiple confounding life course factors, detecting modest neurotoxic effects with small sample sizes (median, 131 children; interquartile range, 50–372), selection of sensitive neurodevelopmental outcomes at appropriate ages for different developmental domains, insufficient length of follow-up (median age, 6 years; interquartile range, 2–12 years), and sample attrition. We discuss potential solutions to these challenges. Further adequately powered, multicenter, prospective randomized controlled trials of anesthetic-induced neurotoxicity in children are required. However, we believe that the inherent methodological challenges of studying anesthetic-induced neurotoxicity necessitate the parallel use of well-designed observational cohort studies.
- 1 April 2019
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 128 (4) , 681-694
Open AccessAssessing Long-term Neurodevelopmental Outcome Following General Anesthesia in Early Childhood: Challenges and Opportunities
Neurodegeneration has been reported in young animals after exposure to all commonly used general anesthetic agents. The brain may be particularly vulnerable to anesthetic toxicity during peak synaptogenesis (in gestation and infancy). Human studies of long-term neurodevelopmental outcome following general anesthesia in early childhood report contradictory findings. This review assesses the strengths and deficiencies in human research methodologies to inform future studies. We identified 76 studies, published between 1990 and 2017, of long-term neurodevelopmental outcome following early childhood or in utero general anesthesia exposure: 49 retrospective, 9 ambidirectional, 17 prospective cohort studies, and 1 randomized controlled trial. Forty-nine studies were explicitly concerned with anesthetic-induced neurotoxicity. Full texts were appraised for methodological challenges and possible solutions. Major challenges identified included delineating effects of anesthesia from surgery, defining the timing and duration of exposure, selection of a surgical cohort and intervention, addressing multiple confounding life course factors, detecting modest neurotoxic effects with small sample sizes (median, 131 children; interquartile range, 50–372), selection of sensitive neurodevelopmental outcomes at appropriate ages for different developmental domains, insufficient length of follow-up (median age, 6 years; interquartile range, 2–12 years), and sample attrition. We discuss potential solutions to these challenges. Further adequately powered, multicenter, prospective randomized controlled trials of anesthetic-induced neurotoxicity in children are required. However, we believe that the inherent methodological challenges of studying anesthetic-induced neurotoxicity necessitate the parallel use of well-designed observational cohort studies.
- 6 November 2017
- Published by Wiley in Pediatric Anesthesia
- Vol. 27 (12) , 1174-1175
Xenon‐augmented pediatric anesthesia: A small step closer?
- 6 November 2017
- Published by Wiley in Pediatric Anesthesia
- Vol. 27 (12) , 1174-1175
Xenon‐augmented pediatric anesthesia: A small step closer?
- Open Access
- 1 April 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 363, 140-144
Xenon depresses aEEG background voltage activity whilst maintaining cardiovascular stability in sedated healthy newborn pigs
- 1 April 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 363, 140-144
Open AccessXenon depresses aEEG background voltage activity whilst maintaining cardiovascular stability in sedated healthy newborn pigs
- Open Access
- 1 November 2015
- Published by Elsevier in Resuscitation
- Vol. 96, 214-219
The effect of resuscitation in 100% oxygen on brain injury in a newborn rat model of severe hypoxic-ischaemic encephalopathy
- 1 November 2015
- Published by Elsevier in Resuscitation
- Vol. 96, 214-219
Open AccessThe effect of resuscitation in 100% oxygen on brain injury in a newborn rat model of severe hypoxic-ischaemic encephalopathy
- 1 June 2015
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 120 (6) , 1331-1336
The Feasibility of Using a Portable Xenon Delivery Device to Permit Earlier Xenon Ventilation with Therapeutic Cooling of Neonates During Ambulance Retrieval
Therapeutic hypothermia is the standard of care after perinatal asphyxia. Preclinical studies show 50% xenon improves outcome, if started early. During a 32-patient study randomized between hypothermia only and hypothermia with xenon, 5 neonates were given xenon during retrieval using a closed-circuit incubator-mounted system. Without xenon availability during retrieval, 50% of eligible infants exceeded the 5-hour treatment window. With the transportable system, 100% were recruited. Xenon delivery lasted 55 to 120 minutes, using 174 mL/h (117.5-193.2) (median [interquartile range]), after circuit priming (1300 mL). Xenon delivery during ambulance retrieval was feasible, reduced starting delays, and used very little gas.
- 1 June 2015
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 120 (6) , 1331-1336
The Feasibility of Using a Portable Xenon Delivery Device to Permit Earlier Xenon Ventilation with Therapeutic Cooling of Neonates During Ambulance Retrieval
Therapeutic hypothermia is the standard of care after perinatal asphyxia. Preclinical studies show 50% xenon improves outcome, if started early. During a 32-patient study randomized between hypothermia only and hypothermia with xenon, 5 neonates were given xenon during retrieval using a closed-circuit incubator-mounted system. Without xenon availability during retrieval, 50% of eligible infants exceeded the 5-hour treatment window. With the transportable system, 100% were recruited. Xenon delivery lasted 55 to 120 minutes, using 174 mL/h (117.5-193.2) (median [interquartile range]), after circuit priming (1300 mL). Xenon delivery during ambulance retrieval was feasible, reduced starting delays, and used very little gas.